Growth, lifetime, directional movement and myosin-dependent motility of mutant keratin granules in cultured cells.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 01 2021
27 01 2021
Historique:
received:
13
11
2020
accepted:
08
01
2021
entrez:
28
1
2021
pubmed:
29
1
2021
medline:
22
9
2021
Statut:
epublish
Résumé
Intermediate filament polypeptides (IFPs) are prominent components of cytoplasmic aggregates, which are pathognomonic for multiple diseases. Recent observations in cultured cells suggest that they are dynamic and subject to regulated turnover. The emerging concept is that multiple factors contribute to motility and turnover of IFP-containing aggregates. To understand their relative contribution, quantitative tools are needed. The current study addresses this need using epithelial cells producing mutant keratin IFPs that have been identified as the cause of the hereditary blister-forming skin disease epidermolysis bullosa simplex. Digital image analysis of individual granules allowed mapping of their complete life cycle, with information on multiple characteristics at any given time-point. The deduced signet features revealed rapid granule fusion and directed transport from the periphery towards the cell centre, and a limited, ~ 30 min lifetime with a slow, continuous growth phase followed by fast disassembly. As paradigmatic proof-of-principle, we demonstrate that inhibition of myosin II selectively reduces granule movement, linking keratin granule motility to retrograde cortical acto-myosin flow. The newly developed methods and established parameters will help in the characterization of known and the identification of novel regulators of IFP-containing aggregates.
Identifiants
pubmed: 33504849
doi: 10.1038/s41598-021-81542-8
pii: 10.1038/s41598-021-81542-8
pmc: PMC7840912
doi:
Substances chimiques
Keratins
68238-35-7
Myosins
EC 3.6.4.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2379Références
Biomed Res Int. 2017;2017:7804251
pubmed: 28246604
Cell Mol Life Sci. 2016 Nov;73(21):4101-20
pubmed: 27141937
Cell Mol Life Sci. 2020 Nov;77(21):4397-4411
pubmed: 31912195
Trends Biochem Sci. 2018 Sep;43(9):700-713
pubmed: 30057142
J Cell Biol. 2011 Sep 5;194(5):669-78
pubmed: 21893596
Arch Biochem Biophys. 2011 Apr 15;508(2):123-37
pubmed: 21176769
J Struct Biol. 2002 Jan-Feb;137(1-2):82-96
pubmed: 12064936
Mol Biol Cell. 2004 Mar;15(3):990-1002
pubmed: 14668478
Br J Dermatol. 2003 Jul;149(1):46-58
pubmed: 12890194
J Cell Sci. 2002 Nov 15;115(Pt 22):4341-51
pubmed: 12376565
J Cell Biol. 2006 May 8;173(3):341-8
pubmed: 16682525
J Clin Invest. 2009 Jul;119(7):1784-93
pubmed: 19587453
Acta Neuropathol. 2013 Jan;125(1):47-75
pubmed: 23143191
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
J Cell Sci. 2010 Jul 1;123(Pt 13):2266-72
pubmed: 20554896
Exp Cell Res. 2009 Oct 15;315(17):2995-3003
pubmed: 19616543
Exp Cell Res. 2007 Aug 1;313(13):2766-79
pubmed: 17604020
J Cell Sci. 2004 Oct 15;117(Pt 22):5233-43
pubmed: 15454576
Exp Eye Res. 2005 Jun;80(6):777-85
pubmed: 15939033
Cell. 1991 Sep 20;66(6):1301-11
pubmed: 1717157
Cell Tissue Res. 2015 Jun;360(3):609-20
pubmed: 25567110
J Invest Dermatol. 2011 Aug;131(8):1684-91
pubmed: 21490615
J Invest Dermatol. 2015 Oct;135(10):2437-2445
pubmed: 25961909
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Cell. 1991 Jan 25;64(2):365-80
pubmed: 1703046
J Cell Sci. 1995 Nov;108 ( Pt 11):3463-71
pubmed: 8586658
J Cell Biol. 2018 Dec 3;217(12):4314-4330
pubmed: 30389720
Biophys J. 1991 Oct;60(4):910-21
pubmed: 1742458
J Cell Biol. 1991 Dec;115(6):1661-74
pubmed: 1721910
J Invest Dermatol. 1992 Dec;99(6):671-4
pubmed: 1281858
Dermatologica. 1982 Apr;164(4):221-35
pubmed: 7084543
J Cell Biol. 2014 Jan 20;204(2):231-45
pubmed: 24446482
Acta Pharmacol Sin. 2010 Jun;31(6):725-32
pubmed: 20453870
Mol Biol Cell. 2012 Mar;23(5):834-52
pubmed: 22219382
J Cell Biol. 2007 Jun 4;177(5):795-807
pubmed: 17535969
Neuropathology. 2012 Aug;32(4):440-6
pubmed: 22118268
FASEB J. 2019 Jan;33(1):388-399
pubmed: 29944446
J Invest Dermatol. 2018 Aug;138(8):1871-1873
pubmed: 29481904
Mol Neurodegener. 2019 May 16;14(1):19
pubmed: 31097008
Nat Methods. 2008 Jul;5(7):605-7
pubmed: 18536722
Angew Chem Int Ed Engl. 2014 Jul 28;53(31):8211-5
pubmed: 24954740
Hepatology. 2015 Dec;62(6):1858-69
pubmed: 26126491
Nat Cell Biol. 2006 Mar;8(3):215-26
pubmed: 16501565
J Cell Sci. 2020 Jul 29;133(14):
pubmed: 32616561
Int Rev Cell Mol Biol. 2017;330:171-225
pubmed: 28215532
EBioMedicine. 2019 Jun;44:502-515
pubmed: 31078522
Hum Mutat. 2010 Apr;31(4):466-76
pubmed: 20151404